Literature DB >> 21181220

Th-17 associated cytokines in patients with reactive arthritis/undifferentiated spondyloarthropathy.

Amit Kumar Singh1, Ramnath Misra, Amita Aggarwal.   

Abstract

We and others have previously shown that IL-17 is elevated in the synovial fluid of patients with reactive arthritis (ReA)/undifferentiated spondyloarthropathy (uSpA) having acute synovitis. Major source for IL-17 is Th17 cells, which differentiate from Th0 cells under the influence of TGF-β and IL-6, IL1-β and are maintained by IL-21 and 23. There is a paucity of data on these cytokines in ReA/uSpA. Thus, we measured the levels of Th-17 differentiating and maintaining cytokines in synovial fluid of patients with ReA and uSpA. Fifty patients with ReA/uSpA (ReA 24, uSpA 26), 19 patients with rheumatoid arthritis (RA) and 11 patients with osteoarthritis (OA) were included in the study. Synovial fluid (SF) were collected from knee joint and stored at -80°C until analysis. Cytokines were assayed using ELISA in SF specimens. The median IL-17A levels were significantly elevated in ReA (48.3 pg/ml) and uSpA (32.5 pg/ml) as compared to non-inflammatory OA controls (<7.8 pg/ml; p < 0.0001), while comparable to RA (57.9 pg/ml). Further, IL-6 median values were higher in ReA (25.2 ng/ml) and uSpA (13.6 ng/ml) as compared to OA (0.76 ng/ml; p < 0.0001), and comparable to RA (15.8 ng/ml). The median levels of IL-1β, IL-21 levels were elevated in ReA, uSpA and RA as compared to OA but were not statistically significant. TGF-β levels in ReA and uSpA were similar to OA but lower than in RA (4340 pg/ml; p < 0.05). IL-23 was not detectable in any synovial fluid sample. However, levels of these cytokines did not correlate with disease activity parameters. Significant positive correlation was observed between IL-17 and IL-1β (r = 0.38, p < 0.005), IL-17 and IL-6 (r = 0.659, p < 0.0001), and IL-1β and IL-6 (r = 0.391, p < 0.0001) in ReA and uSpA group. Inflammatory synovitis in ReA/uSpA is mediated by pro-inflammatory cytokines like IL-17, IL-6, IL-1β, and IL-21. However, IL-23 was not detectable in SF. Good correlation between IL-17, IL-6, and IL 1β suggest that either they are co-regulated or they regulate each other.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181220     DOI: 10.1007/s10067-010-1646-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  33 in total

Review 1.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis.

Authors:  S Bas; T K Kvien; N Buchs; T Fulpius; C Gabay
Journal:  Rheumatology (Oxford)       Date:  2003-03       Impact factor: 7.580

Review 3.  The sacroiliac joint in the spondyloarthropathies.

Authors:  J Braun; J Sieper
Journal:  Curr Opin Rheumatol       Date:  1996-07       Impact factor: 5.006

4.  Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases.

Authors:  Shilpi Agarwal; Ramnath Misra; Amita Aggarwal
Journal:  J Rheumatol       Date:  2008-01-15       Impact factor: 4.666

5.  The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo.

Authors:  Mandy J McGeachy; Yi Chen; Cristina M Tato; Arian Laurence; Barbara Joyce-Shaikh; Wendy M Blumenschein; Terrill K McClanahan; John J O'Shea; Daniel J Cua
Journal:  Nat Immunol       Date:  2009-02-01       Impact factor: 25.606

6.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

7.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

8.  Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy.

Authors:  Rajeev Singh; Amita Aggarwal; Ramnath Misra
Journal:  J Rheumatol       Date:  2007-10-15       Impact factor: 4.666

9.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.

Authors:  Kojiro Sato; Ayako Suematsu; Kazuo Okamoto; Akira Yamaguchi; Yasuyuki Morishita; Yuho Kadono; Sakae Tanaka; Tatsuhiko Kodama; Shizuo Akira; Yoichiro Iwakura; Daniel J Cua; Hiroshi Takayanagi
Journal:  J Exp Med       Date:  2006-11-06       Impact factor: 14.307

10.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

View more
  17 in total

1.  Synovial fluid and serum levels of IL-17, IL-23, and CCL-20 in rheumatoid arthritis and psoriatic arthritis: a Tunisian cross-sectional study.

Authors:  Dalila Mrabet; Lilia Laadhar; Héla Sahli; Béchir Zouari; Slim Haouet; Sondès Makni; Slaheddine Sellami
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

Review 2.  Secukinumab: a promising therapeutic option in spondyloarthritis.

Authors:  Hernan Maldonado-Ficco; Rodolfo Perez-Alamino; José A Maldonado-Cocco
Journal:  Clin Rheumatol       Date:  2016-07-20       Impact factor: 2.980

Review 3.  Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.

Authors:  Smriti K Raychaudhuri; Ankit Saxena; Siba P Raychaudhuri
Journal:  Clin Rheumatol       Date:  2015-05-05       Impact factor: 2.980

4.  Emerging role of IL-23 in rheumatoid arthritis.

Authors:  Feng-Lai Yuan; Xia Li; Jun-Ming Sun; Rui-Sheng Xu
Journal:  Clin Rheumatol       Date:  2011-06-18       Impact factor: 2.980

5.  Salmonella enterica induces joint inflammation and expression of interleukin-17 in draining lymph nodes early after onset of enterocolitis in mice.

Authors:  Mariángeles Noto Llana; Sebastián Hernán Sarnacki; María Victoria Vázquez; Alejandra Sonia Gartner; Mónica Nancy Giacomodonato; María Cristina Cerquetti
Journal:  Infect Immun       Date:  2012-04-09       Impact factor: 3.441

6.  Recombinant Salmonella typhimurium outer membrane protein A is recognized by synovial fluid CD8 cells and stimulates synovial fluid mononuclear cells to produce interleukin (IL)-17/IL-23 in patients with reactive arthritis and undifferentiated spondyloarthropathy.

Authors:  S Chaurasia; A K Shasany; A Aggarwal; R Misra
Journal:  Clin Exp Immunol       Date:  2016-05-23       Impact factor: 4.330

Review 7.  IL-23/IL-17 axis in spondyloarthritis-bench to bedside.

Authors:  Siba P Raychaudhuri; Smriti K Raychaudhuri
Journal:  Clin Rheumatol       Date:  2016-04-13       Impact factor: 2.980

8.  Inflammatory bowel disease-related arthritis - clinical evaluation and possible role of cytokines.

Authors:  Joanna Dmowska-Chalaba; Ewa Kontny
Journal:  Reumatologia       Date:  2015-12-08

9.  Association between IL-17 and IgA in the joints of patients with inflammatory arthropathies.

Authors:  Ricardo Javier Eliçabe; Juan Eduardo Silva; Mabel Noemí Dave; María Gabriela Lacoste; Héctor Tamashiro; Rodrigo Blas; Alicia Munarriz; Gabriel Adrián Rabinovich; María Silvia Di Genaro
Journal:  BMC Immunol       Date:  2017-02-06       Impact factor: 3.615

10.  Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.

Authors:  Hanna Przepiera-Będzak; Katarzyna Fischer; Marek Brzosko
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.